Poly(<i>N</i>-vinylcaprolactam) containing solid lipid polymer hybrid nanoparticles for controlled delivery of a hydrophilic drug gemcitabine hydrochloride-Reference-Cited by-同舟云学术

Poly(N-vinylcaprolactam) containing solid lipid polymer hybrid nanoparticles for controlled delivery of a hydrophilic drug gemcitabine hydrochloride

Published:2022 Issue:27 Volume:12 Page:17621-17628
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Surapaneni Sai Geetika¹²,Ambade Ashootosh V.¹²^ORCID

Affiliation:

1. Polymer Science and Engineering Division, CSIR-National Chemical Laboratory, Dr Homi Bhabha Road, Pune – 411008, India

2. Academy of Scientific and Innovative Research (AcSIR), Ghaziabad – 201002, India

Abstract

A hydrophilic polymer, poly(N-vinylcaprolactam), incorporated into solid lipid nanoparticles (SLNs) imparts better encapsulation and controlled release of gemcitabine.

Funder

National Chemical Laboratory

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2022/RA/D2RA02845J

Reference58 articles.

1. Innovative approaches for cancer treatment: current perspectives and new challenges

2. Gemcitabine and Carboplatin in Second-Line Ovarian Cancer

3. Gemcitabine Plus Paclitaxel in Breast Cancer

4. Phase II study of gemcitabine in patients with advanced pancreatic cancer

5. Phase II study of second-line gemcitabine in sensitive or refractory small cell lung cancer

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rational design of solid lipid-polymer hybrid nanoparticles: An innovative glycoalkaloids-carrier with potential for topical melanoma treatment;Colloids and Surfaces B: Biointerfaces;2024-10

2. Statistical modeling, optimization and characterization of andrographolide loaded emulgel for its therapeutic application on skin cancer through enhancing its skin permeability;Saudi Pharmaceutical Journal;2024-06

3. Emerging Trends in Hybrid Nanoparticles: Revolutionary Advances and Promising Biomedical Applications;Current Drug Metabolism;2024-05

4. An update on strategies for optimizing polymer-lipid hybrid nanoparticle-mediated drug delivery: exploiting transformability and bioactivity of PLN and harnessing intracellular lipid transport mechanism;Expert Opinion on Drug Delivery;2024-02

5. General justification in terms of effectiveness and toxicities for the use of nanocarriers;Journal of Nanoparticle Research;2023-09